ProfileGDS4132 / 222265_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 78% 78% 65% 70% 73% 76% 76% 72% 70% 75% 79% 79% 72% 71% 73% 75% 78% 73% 73% 78% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101256.32578
GSM201543Muscle PCOS pioglitazone 121243.55278
GSM201544Muscle PCOS pioglitazone 161189.55965
GSM201545Muscle PCOS pioglitazone 201224.48670
GSM201829Muscle PCOS pioglitazone 231239.59773
GSM201830Muscle PCOS pioglitazon 251246.95376
GSM201831Muscle PCOS pioglitazone 271250.73776
GSM201832Muscle PCOS pioglitazone 31209.26372
GSM201833Muscle PCOS pioglitazone 41199.61670
GSM201834Muscle PCOS pioglitazone 81239.24775
GSM201835Muscle PCOS after pioglitazone 102265.40779
GSM201836Muscle PCOS after pioglitazone 122271.38279
GSM201837Muscle PCOS after pioglitazone 162203.85572
GSM201838Muscle PCOS after pioglitazone 202209.96871
GSM201839Muscle PCOS after pioglitazone 232226.25173
GSM201840Muscle PCOS after pioglitazone 252248.63275
GSM201841Muscle PCOS after pioglitazone 272254.16878
GSM201842Muscle PCOS after pioglitazone 32202.54673
GSM201843Muscle PCOS after pioglitazone 42220.92673
GSM201844Muscle PCOS after pioglitazone 82271.34578